NCT04258306View on ClinicalTrials.gov

Pilot Study to Evaluate the Plasma Profile of Revifast

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

November 20, 2017

Study Completion Date

April 1, 2019

Conditions
Nutrient; ExcessProduct Use Issue
Interventions
DIETARY_SUPPLEMENT

Revifast

Revifast® is based on natural resveratrol supported on Magnesium hydroxide. Revifast® particles confer an improved dissolution rate in tests that mimic the gastric environment compared to Polygonum cuspidatum resveratrol (98%).

DIETARY_SUPPLEMENT

pure resveratrol

resveratrol extracted from Polygonum cuspidatum resveratrol (98%).

Trial Locations (1)

06131

Deparment of Chemistry, Biology and Biotechnology, Perugia

All Listed Sponsors
lead

Bernard Fioretti

OTHER

NCT04258306 - Pilot Study to Evaluate the Plasma Profile of Revifast | Biotech Hunter | Biotech Hunter